Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (Clinical Research in Cardiology, (2020), 109, 3, (331-338), 10.1007/s00392-019-01513-y)

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).

Cite

CITATION STYLE

APA

Santema, B. T., Chan, M. M. Y., Tromp, J., Dokter, M., van der Wal, H. H., Emmens, J. E., … Voors, A. A. (2021, August 1). Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (Clinical Research in Cardiology, (2020), 109, 3, (331-338), 10.1007/s00392-019-01513-y). Clinical Research in Cardiology. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s00392-020-01762-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free